SUN PHARMA'S HISTORY Sun Pharmaceuticals was founded by Mr. Dilip Shanghvi in 1983 in Vapi, Gujarat with five products for the treatment of psychiatric diseases. Cardiology products were introduced in 1987 by Gastroenterology Products in 1989. Today, it is the largest chronic prescription company in India and a market leader in psychiatry, neurology, cardiology, orthopedics, ophthalmology, gastroenterology and nephrology. The 2014 acquisition of Ranbaxy has made the company the largest pharma company in India, the largest Indian pharma company in the US, and the 5th largest specialty generic company globally. More than 72% of Sun Pharma's sales are from markets outside India, mainly in the states. The US is the largest market, accounting for about 50% of turnover; All, formulations or finished dosage forms, account for 93% of the turnover. Manufacturing is at 26 locations including plants in the US, Canada, Brazil, Mexico and Israel. In the US, the company markets a la...